Pharmacokinetics and efficacy of tank-water administered BRAF-inhibitor dabrafenib in a zebrafish model of BRAF-mutant melanoma
Jenna Villman, Nikol Dibus, Jonas Huhn, Anna-Mari Haapanen-Saaristo, Ilia Evstafev, Alex M. Dickens, Oliver Scherf‐Clavel, Ilkka Paatero, Kari J. Kurppa
This study evaluates the pharmacokinetics and efficacy of tank-water administered dabrafenib in zebrafish with BRAF-mutant melanoma, showing rapid absorption, short half-life, and effective treatment with minimal toxicity.
bioRxiv · Oct 12, 2025 · PreprintCancer Biology